Impact of limited clinical data and increasing pathogen resistance on choice of antibacterial therapy

• There is a need for:

  • accurate prediction of efficacy
  • newer dosage regimens
  • newer antibacterials
  • revised susceptibility breakpoints
  • statistically valid clinical studies

Previous slide

Next slide

Back to first slide

View graphic version